Non-Surgical Weight Loss: A Guide To Effective Weight Loss Medication

Until recently, many medical treatments for weight loss were costly and invasive. Now, a new generation of medication is changing the way we approach long-term weight loss. So, what are these non-surgical treatments, how do they work and why are people choosing them over other weight loss methods like surgical procedures? Our Levity experts explain. 

Understanding weight loss surgery

In the past, people seeking treatment for obesity would have limited treatment paths to choose from, most of which were surgical options. Bariatric surgery is a type of surgery that makes your stomach smaller, which makes you feel full faster so you eat less. Examples of bariatric procedures include gastric bypass, gastric band and sleeve gastrectomy, and they involve parts of your stomach being altered or removed entirely. They're performed under general anaesthetic using minimally invasive techniques, but they're still considered permanent, major operations with four to six weeks of recovery time afterwards.

These procedures are available on the NHS if your BMI is 40 or over, or between 35-39.9 and have an existing obesity-related condition that may improve with weight loss, such as type 2 diabetes or high blood pressure. [1] Availability of the service varies around the country, meaning many people pay for expensive private surgeries. Although safe, weight loss surgery can put you at risk of complications, including: blood clots, stomach leaks, gut blockages and infection. [2]

For these reasons, many people are turning to non-invasive procedures and treatments instead.

Introducing: GLP-1s

Glucagon-like peptide-1 receptor agonists, or GLP-1s, have revolutionised the way we now treat obesity. They were originally developed as treatments for type-2 diabetes, but clinical studies found they were also highly effective at aiding weight loss. [3]

They work by mimicking a naturally occurring hormone in your gut: glucagon-like peptide-1. This hormone is responsible for regulating your blood sugar, slowing down digestion and suppressing appetite. It's part of the incretin system, a group of gut-derived hormones that regulate the amount of insulin released after you eat a meal.

GLP-1 medications are taken as a subcutaneous injection into the fatty layer of tissue beneath your skin using a pre-filled injection pen.

How do GLP-1s help you lose weight?

GLP-1s aid weight loss in two key ways:

Controlling your blood sugar

GLP-1s enhance insulin secretion in response to elevated blood sugar levels after a meal. [4] This helps improve your metabolic health. 

Regulating your appetite

GLP-1 medications target the appetite centre in your brain, increasing satiety and reducing hunger signals. [5] They also slow gastric emptying, or the rate food leaves your stomach after you eat. [6] Many people taking GLP-1s report a decreased desire to overeat as a result. [5]

Popular GLP-1 medications

One of the most well-known GLP-1 medications is semaglutide, the active ingredient in branded treatments like Ozempic and Wegovy. Research shows that people who take semaglutide lose 14.9% of their body weight in 68 weeks, on average. [7]

You may have also heard of tirzepatide, or Mounjaro. This drug is a dual-action GIP (gastric inhibitory polypeptide) and GLP-1 receptor agonist, meaning it mimics two gut hormones instead of just one. That makes it one of the most effective drugs on the market, with the maximum dose helping patients lose up to 20.9% of their body weight in 72 weeks. [8]

Who's eligible for GLP-1s?

GLP-1s are eligible to be prescribed to treat obesity. They can be  prescribed to people with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher with weight-related medical conditions such as type-2 diabetes, prediabetes, high cholesterol or high blood pressure. [9] These BMI cutoff values can be lower depending on ethnicity. 

Before starting treatment

If you're considering non-surgical weight loss options like a GLP-1 medication, it's important for you to consider the following:

  • A thorough health history assessment by a medical professional is crucial to determine your eligibility for specific medications and to assess any potential risks or side effects associated with their use.
  • Medication alone is not a guaranteed solution. Sustainable weight loss requires long-term lifestyle changes, including eating a healthy diet and increasing physical activity levels.
  • Understanding potential side effects is essential — common side effects may include nausea, diarrhoea or constipation. Serious side effects are rare, but should be discussed with your healthcare provider.
  • Weight loss medications require long-term use for sustained results. You should be committed to your entire treatment plan and regular follow-ups with your healthcare provider to make sure you're responding well to your medication.

Need help achieving your weight loss goals?

Combined with a healthy diet and regular exercise, weight loss medications can boost your weight loss results. To learn more about non-surgical weight loss treatments at Levity, start an online consultation today.

References:

  1. Introduction to Bariatric Surgery (weight loss surgery) [Internet]. University Hospitals Sussex NHS Foundation Trust. 2023. Available from: https://www.uhsussex.nhs.uk/resources/information-about-bariatric-surgery/
  2. NHS Choices. Overview - Weight loss surgery [Internet]. NHS. 2019. Available from: https://www.nhs.uk/conditions/weight-loss-surgery/
  3. Collins L, Costello RA. Glucagon-like peptide-1 receptor agonists [Internet]. PubMed. Treasure Island (FL): StatPearls Publishing; 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551568/
  4. Garvey WT, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine [Internet]. 2022 Oct 1;28(10):2083–91. Available from: https://www.nature.com/articles/s41591-022-02026-4
  5. Blundell J, Finlayson G, Axelsen M, Flint A, Gibbons C, Kvist T, et al. Effects of once‐weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obesity and Metabolism [Internet]. 2017 May 5;19(9):1242–51. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573908/
  6. Silveira SQ, da Silva LM, de Campos Vieira Abib A, de Moura DTH, de Moura EGH, Santos LB, et al. Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopy. Journal of Clinical Anesthesia [Internet]. 2023 Aug 1 [cited 2023 Mar 3];87:111091. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0952818023000417?dgcid=coauthor 
  7. Wilding JPH, Batterham RL, Calanna S. Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine [Internet]. 2021 Feb 10;384(11):989–1002. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
  8. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine [Internet]. 2022 Jun 4;387(3). Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
  9. Four-dose Mounjaro “KwikPen” approved by MHRA for diabetes and weight management [Internet]. GOV.UK. Available from: https://www.gov.uk/government/news/four-dose-mounjaro-kwikpen-approved-by-mhra-for-diabetes-and-weight-management

Continue reading